Earnout Structures in M&A

Definition

An earnout is a contractual provision in an M&A transaction where a portion of the purchase price is contingent on the target company achieving specified financial or operational milestones post-close. Earnouts bridge valuation gaps between buyer and seller, incentivize seller retention, and allocate risk for uncertain future performance. In 2024, earnouts appeared in 22% of all M&A deals, with the median earnout size at 31% of closing payments outside life sciences. [src4]

Key Properties

• Prevalence: 22% of M&A deals in 2024 include earnout provisions
• Median earnout size: 31% of closing payment value (non-life-sciences)
• Most common metric: Revenue (62%) vs. EBITDA/earnings (22%)
• Typical duration: 1-3 years post-close
• Realization rate: ~21 cents on the dollar on average; 28% are contested

Constraints

• Ambiguous metric definitions are the leading cause of earnout disputes [src2]
• Buyer operational control creates inherent conflicts of interest [src3]
• Revenue-based earnouts may incentivize top-line growth at the expense of profitability [src4]
• ASC 805 requires fair value measurement at close with P&L revaluations [src5]
• Earnout periods beyond 3 years significantly increase litigation risk [src1]

Framework Selection Decision Tree

START — User needs to structure M&A consideration
├── Is there a valuation gap between buyer and seller?
│   ├── YES → Earnout structures ← YOU ARE HERE
│   ├── NO, but seller retention is critical → Employment/retention agreements
│   └── NO, clean exit preferred → Fixed purchase price
├── What drives the gap?
│   ├── Uncertain revenue trajectory → Revenue-based earnout
│   ├── Profitability concerns → EBITDA-based earnout
│   ├── Regulatory milestones → Milestone-based earnout (binary)
│   └── Technology risk → Escrow/holdback instead
├── How long is the uncertainty horizon?
│   ├── Less than 1 year → Short earnout or price adjustment mechanism
│   ├── 1-3 years → Standard earnout structure
│   └── 3+ years → Consider alternatives (CVRs, milestone payments)
└── Is the seller staying post-close?
    ├── YES → Earnout tied to business unit performance
    └── NO → Earnout tied to company-wide metrics

Application Checklist

Step 1: Define earnout metrics precisely

• Inputs needed: Proposed metric, target's historical financials, buyer's post-close operating plan
• Output: Metric definition schedule with explicit accounting policy elections and exclusions
• Constraint: Every metric must reference a specific accounting standard — "EBITDA" without definition is litigable [src2]

Step 2: Set targets and payment structure

• Inputs needed: Financial projections (base, upside, downside), comparable earnout terms
• Output: Tiered payment schedule with threshold, target, and stretch levels
• Constraint: Earnout cap should not exceed 40-50% of total deal value [src3]

Step 3: Negotiate operational covenants

• Inputs needed: Buyer's integration plan, seller's resource allocation concerns
• Output: Covenant package covering minimum investment and business conduct standards
• Constraint: Buyer must commit to "ordinary course consistent with past practice" operations [src1]

Step 4: Establish dispute resolution mechanism

• Inputs needed: Preferred forum, independent accountant process, timeline requirements
• Output: Binding dispute resolution clause with notice period and arbitration
• Constraint: Must include a binding mechanism — 28% of earnouts are contested [src4]

Anti-Patterns

Wrong: Using "EBITDA" without a detailed definition schedule

Parties agree to "EBITDA as calculated consistent with GAAP" without specifying treatment of restructuring charges, management fees, or one-time items. [src2]

Correct: Attach an accounting policy schedule to the purchase agreement

Define EBITDA with a line-by-line schedule specifying every adjustment, referencing the target's historical accounting practices. [src3]

Wrong: Giving the buyer full operational discretion during the earnout period

Buyers who can redirect resources, change pricing, or integrate operations freely can undermine earnout metrics. [src1]

Correct: Include operational covenants protecting earnout achievability

Negotiate minimum investment thresholds, headcount maintenance, and "ordinary course" operating requirements. [src3]

Wrong: Using financial metrics when value depends on regulatory approval

For biotech deals where value depends on FDA approval, revenue or EBITDA earnouts are meaningless pre-revenue. [src4]

Correct: Use binary milestone payments for regulatory or technical targets

Structure as fixed payments upon achievement of objectively verifiable milestones. [src4]

Common Misconceptions

Misconception: Earnouts primarily benefit the seller by capturing upside.
Reality: Earnouts achieve only ~21 cents on the dollar on average. They primarily benefit the buyer by deferring risk. [src4]

Misconception: Revenue-based earnouts are simple and dispute-free.
Reality: Revenue earnouts still generate disputes around recognition timing, customer allocation, and product bundling. [src2]

Misconception: Longer earnout periods capture more value.
Reality: Periods beyond 3 years dramatically increase dispute risk, seller disengagement, and accounting complexity. [src1]

Comparison with Similar Concepts

When This Matters

Fetch this when a user asks about structuring contingent consideration in M&A, designing earnout metrics and payment schedules, understanding earnout accounting under ASC 805, or resolving earnout disputes.